Management of Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Review
Peng Wu,* Yumei Zhao,* Li Xiang, Linglin Yang Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Linglin YangDepartment of Oncology, The Affiliated Hospital...
Main Authors: | Wu P, Zhao Y, Xiang L, Yang L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-02-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/management-of-chemotherapy-for-stage-ii-nasopharyngeal-carcinoma-in-th-peer-reviewed-article-CMAR |
Similar Items
-
Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non‐metastatic stage T4 nasopharyngeal carcinoma in IMRT era
by: Yuming Zheng, et al.
Published: (2024-02-01) -
A Systematic Review and Meta-Analysis of Studies Comparing Concurrent Chemoradiotherapy With Radiotherapy Alone in the Treatment of Stage II Nasopharyngeal Carcinoma
by: Yao-Can Xu, et al.
Published: (2022-07-01) -
The impairment of induction chemotherapy for stage II nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy with or without concurrent chemotherapy: A propensity score‐matched analysis
by: YuLin Lai, et al.
Published: (2023-02-01) -
A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients
by: Ya-Hui Yu, et al.
Published: (2016-06-01) -
Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis
by: Ji-Jin Yao, et al.
Published: (2017-03-01)